ANAB vs TROW · rev $234.6M vs P/E 12, rev $3.76B
AnaptysBio Inc (ANAB) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
ANAB currently screens at market cap $1.62B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the ANAB and TROW stock pages for the full models.
Not investment advice.